Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion. 2014

Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata, 9909585, Japan.

Early coronary reperfusion of the ischemic myocardium is a desired therapeutic goal for the preservation of myocardial function. However, reperfusion itself causes additional myocardium injuries. Activation of the diacylglycerol-protein kinase C (DAG-PKC) cascade has been implicated in the cardioprotective effects occurring after ischemia/reperfusion (I/R). DAG kinase (DGK) controls cellular DAG levels by converting DAG to phosphatidic acid, and may act as an endogenous regulator of DAG-PKC signaling. In the present study, we examined the functional role of DGKα in cardiac injury after I/R in in vivo mouse hearts. We generated transgenic mice with cardiac-specific overexpression of DGKα (DGKα-TG). The left anterior descending coronary artery was transiently occluded for 20 min and reperfused for 24 h in DGKα-TG mice and wild-type littermate (WT) mice. The levels of phosphorylation activity of PKCε, extracellular-signal regulated kinase (ERK) 1/2, and p70 ribosomal S6 kinase (p70S6K) were increased after I/R in WT mouse hearts. However, in DGKα-TG mice, activation of PKCε, ERK1/2, and p70S6K was attenuated compared to WT mice. After 24 h, Evans blue/triphenyltetrazolium chloride double staining and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining showed that DGKα-TG mice had significantly larger myocardial infarctions and larger numbers of TUNEL-positive cardiomyocytes than WT mice. Echocardiography and cardiac catheterization revealed that left ventricular systolic function was more severely depressed in DGKα-TG mice than in WT mice after I/R. These findings suggest that DGKα exacerbates I/R injury by inhibiting the cardioprotective effects of PKCε, ERK1/2, and p70S6K activation.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013599 Systole Period of contraction of the HEART, especially of the HEART VENTRICLES. Systolic Time Interval,Interval, Systolic Time,Intervals, Systolic Time,Systoles,Systolic Time Intervals,Time Interval, Systolic,Time Intervals, Systolic
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015428 Myocardial Reperfusion Injury Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion Injury, Myocardial,Injury, Myocardial Reperfusion,Myocardial Ischemic Reperfusion Injury,Injuries, Myocardial Reperfusion,Myocardial Reperfusion Injuries,Reperfusion Injuries, Myocardial
D016277 Ventricular Function, Left The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance. Left Ventricular Function,Function, Left Ventricular,Functions, Left Ventricular,Left Ventricular Functions,Ventricular Functions, Left

Related Publications

Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
March 2022, Circulation research,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
January 2012, PloS one,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
October 2023, Cardiovascular drugs and therapy,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
December 1997, The Annals of thoracic surgery,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
October 1991, The American journal of physiology,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
January 2010, The Journal of surgical research,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
February 1998, The American journal of physiology,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
September 2004, The American journal of pathology,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
June 2013, American journal of physiology. Renal physiology,
Toshiki Sasaki, and Tetsuro Shishido, and Shinpei Kadowaki, and Tatsuro Kitahara, and Satoshi Suzuki, and Shigehiko Katoh, and Akira Funayama, and Shunsuke Netsu, and Tetsu Watanabe, and Kaoru Goto, and Yasuchika Takeishi, and Isao Kubota
January 2021, Redox biology,
Copied contents to your clipboard!